NFE2L2 and neoplasm: However, many studies have reported that persistent overexpression of Nrf2 causes increased resistance of cancer cells to chemotherapeutic drugs, including adriamycin, etoposide, and cisplatin, suggesting that Nrf2 is an important transcription factor for tumor drug resistance (146).